{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T20:43:46Z","timestamp":1786740226133,"version":"build-2736575974"},"reference-count":54,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T00:00:00Z","timestamp":1686614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais (FAPEMIG), Brazil","doi-asserted-by":"publisher","award":["APQ-02167-21"],"award-info":[{"award-number":["APQ-02167-21"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Visceral leishmaniasis (VL) in the Americas is a chronic systemic disease caused by infection with Leishmania infantum parasites. The toxicity of antileishmanial drugs, long treatment course and limited efficacy are significant concerns that hamper adequate treatment against the disease. Studies have shown the promise of an immunotherapeutics approach, combining antileishmanial drugs to reduce the parasitism and vaccine immunogens to activate the host immune system. In the current study, we developed an immunotherapy using a recombinant T cell epitope-based chimeric protein, ChimT, previously shown to be protective against Leishmania infantum, with the adjuvant monophosphoryl lipid A (MPLA) and amphotericin B (AmpB) as the antileishmanial drug. BALB\/c mice were infected with L. infantum stationary promastigotes and later they received saline or were treated with AmpB, MPLA, ChimT\/Amp, ChimT\/MPLA or ChimT\/MPLA\/AmpB. The combination of ChimT\/MPLA\/AmpB significantly reduced the parasite load in mouse organs (p &lt; 0.05) and induced a Th1-type immune response, which was characterized by higher ratios of anti-ChimT and anti-parasite IgG2a:IgG1 antibodies, increased IFN-\u03b3 mRNA and IFN-\u03b3 and IL-12 cytokines and accompanied by lower levels of IL-4 and IL-10 cytokines, when compared to other treatments and controls (all p &lt; 0.05). Organ toxicity was also lower with the ChimT\/MPLA\/AmpB immunotherapy, suggesting that the inclusion of the vaccine and adjuvant ameliorated the toxicity of AmpB to some degree. In addition, the ChimT vaccine alone stimulated in vitro murine macrophages to significantly kill three different internalized species of Leishmania parasites and to produce Th1-type cytokines into the culture supernatants. To conclude, our data suggest that the combination of ChimT\/MPLA\/AmpB could be considered for further studies as an immunotherapy for L. infantum infection.<\/jats:p>","DOI":"10.3390\/biology12060851","type":"journal-article","created":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T02:26:56Z","timestamp":1686709616000},"page":"851","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy of an Immunotherapy Combining Immunogenic Chimeric Protein Plus Adjuvant and Amphotericin B against Murine Visceral Leishmaniasis"],"prefix":"10.3390","volume":"12","author":[{"given":"Danniele L.","family":"Vale","sequence":"first","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7882-215X","authenticated-orcid":false,"given":"Camila S.","family":"Freitas","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel J. L.","family":"Moreira","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Imunopatologia, N\u00facleo de Pesquisas em Ci\u00eancias Biol\u00f3gicas\/NUPEB, Departamento de Ci\u00eancias Biol\u00f3gicas, Insituto de Ci\u00eancias Exatas e Biol\u00f3gicas, Universidade Federal de Ouro Preto, Ouro Preto 35400-000, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda S.","family":"Machado","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7852-0300","authenticated-orcid":false,"given":"Fernanda F.","family":"Ramos","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela A. G.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel S.","family":"Bandeira","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo M.","family":"de Jesus","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grasiele S. V.","family":"Tavares","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8394-4802","authenticated-orcid":false,"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[{"name":"Computational Biology and Chemistry Research Group, Vicerrectorado de Investigaci\u00f3n, Universidad Cat\u00f3lica de Santa Mar\u00eda, Urb. San Jos\u00e9 S\/N, Umacollo, Arequipa 04000, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8890-3030","authenticated-orcid":false,"given":"Alexsandro S.","family":"Galdino","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Biotecnologia de Microrganismos, Universidade Federal de S\u00e3o Jo\u00e3o Del-Rei, Divin\u00f3polis 35501-296, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4713-575X","authenticated-orcid":false,"given":"Ricardo T.","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Departamento de Parasitologia, Instituto de Ci\u00eancias Biol\u00f3gicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edlian L.","family":"Bueno","sequence":"additional","affiliation":[{"name":"Departamento de Parasitologia, Instituto de Ci\u00eancias Biol\u00f3gicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Imunopatologia, N\u00facleo de Pesquisas em Ci\u00eancias Biol\u00f3gicas\/NUPEB, Departamento de Ci\u00eancias Biol\u00f3gicas, Insituto de Ci\u00eancias Exatas e Biol\u00f3gicas, Universidade Federal de Ouro Preto, Ouro Preto 35400-000, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9663-4731","authenticated-orcid":false,"given":"Myron","family":"Christodoulides","sequence":"additional","affiliation":[{"name":"Neisseria Research Group, Molecular Microbiology, School of Clinical and Experimental Sciences, University of Southampton Faculty of Medicine, Southampton General Hospital, Southampton SO16 6YD, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6681-9014","authenticated-orcid":false,"given":"Eduardo A. F.","family":"Coelho","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil"},{"name":"Departamento de Patologia Cl\u00ednica, Col\u00e9gio T\u00e9cnico (COLTEC), Universidade Federal de Minas Gerais, Av. Ant\u00f4nio Carlos, 6627, Belo Horizonte 31270-901, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[{"name":"Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias da Sa\u00fade: Infectologia e Medicina Tropical, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Minas Gerais, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"ref_2","unstructured":"(2023, March 30). World-Health-Organisation. Available online: http:\/\/www.who.int\/topics\/leishmaniasis\/en\/."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniases of the New World: Current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1586\/eri.12.148","article-title":"Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects","volume":"11","author":"Ejazi","year":"2013","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40291-018-0343-y","article-title":"Molecular Diagnosis of Visceral Leishmaniasis","volume":"22","author":"Sundar","year":"2018","journal-title":"Mol. Diagn. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","article-title":"Recent advances and new strategies on leishmaniasis treatment","volume":"104","author":"Roatt","year":"2020","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"106661","DOI":"10.1016\/j.actatropica.2022.106661","article-title":"Amphotericin B: A drug of choice for Visceral Leishmaniasis","volume":"235","author":"Kumari","year":"2022","journal-title":"Acta Trop."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1590\/0037-8682-0138-2015","article-title":"New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment","volume":"48","author":"Ribeiro","year":"2015","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.actatropica.2018.03.016","article-title":"Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review","volume":"182","author":"Mosimann","year":"2018","journal-title":"Acta Trop."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijbiomac.2020.03.019","article-title":"Development of dextrin-amphotericin B formulations for the treatment of Leishmaniasis","volume":"153","author":"Fidalgo","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.ijbiomac.2020.07.193","article-title":"Corrigendum to \u201cDevelopment of dextrin-amphotericin B formulations for the treatment of Leishmaniasis\u201d [Int. J. Biol. Macromol., 15 (2020) 276\u2013288]","volume":"166","author":"Fidalgo","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ponte-Sucre, A., Gamarro, F., Dujardin, J.-C., Barrett, M.P., L\u00f3pez-V\u00e9lez, R., Garc\u00eda-Hern\u00e1ndez, R., Pountain, A.W., Mwenechanya, R., and Papadopoulou, B. (2017). Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0006052"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1155\/2015\/176545","article-title":"Relapse of Visceral Leishmaniasis in an HIV-Infected Patient Successfully Treated with a Combination of Miltefosine and Amphotericin B","volume":"26","author":"McQuarrie","year":"2015","journal-title":"Can. J. Infect. Dis. Med. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.phymed.2016.11.012","article-title":"Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-\u03b3 and IL-12 mediated immune responses in Leishmania donovani infected hamsters","volume":"24","author":"Tripathi","year":"2017","journal-title":"Phytomedicine"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2021.03.011","article-title":"Immunotherapy in treatment of leishmaniasis","volume":"233","author":"Akbari","year":"2021","journal-title":"Immunol. Lett."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"108969","DOI":"10.1016\/j.intimp.2022.108969","article-title":"Immunotherapy for visceral leishmaniasis: A trapeze of balancing counteractive forces","volume":"110","author":"Mazire","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.it.2007.07.004","article-title":"Interleukin-10 and the pathogenesis of human visceral leishmaniasis","volume":"28","author":"Sacks","year":"2007","journal-title":"Trends Immunol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/infdis\/173.6.1515","article-title":"Interleukin-12 Restores Interferon- Production and Cytotoxic Responses in Visceral Leishmaniasis","volume":"173","author":"Bacellar","year":"1996","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.vaccine.2007.11.021","article-title":"Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response","volume":"26","author":"Ramos","year":"2008","journal-title":"Vaccine"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3347\/kjp.2022.60.6.379","article-title":"Leishmania Vaccines: The Current Situation with Its Promising Aspect for the Future","volume":"60","author":"Dinc","year":"2022","journal-title":"Korean J. Parasitol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/eji.200939455","article-title":"Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation","volume":"40","author":"Deak","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1590\/0037-8682-0022-2012","article-title":"Involvement and interactions of different immune cells and their cytokines in human visceral leishmaniasis","volume":"46","author":"Bhattacharya","year":"2013","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Le Rutte, E.A., Coffeng, L.E., Malvolti, S., Kaye, P.M., and de Vlas, S.J. (2020). The potential impact of human visceral leishmaniasis vaccines on population incidence. PLoS Negl. Trop. Dis., 14.","DOI":"10.1101\/2020.05.05.20090480"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1016\/j.vaccine.2009.05.043","article-title":"Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants","volume":"27","author":"Poot","year":"2009","journal-title":"Vaccine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e12359","DOI":"10.1111\/pim.12359","article-title":"A recombinant chimeric protein composed of human and mice-specific CD4+ and CD8+ T-cell epitopes protects against visceral leishmaniasis","volume":"39","author":"Martins","year":"2017","journal-title":"Parasite Immunol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1016\/j.vaccine.2021.04.004","article-title":"A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB\/c mice","volume":"39","author":"Ostolin","year":"2021","journal-title":"Vaccine"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1006\/rtph.2002.1541","article-title":"Safety Evaluation of Monophosphoryl Lipid A (MPL): An Immunostimulatory Adjuvant","volume":"35","author":"Baldricka","year":"2002","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1189\/jlb.0305172","article-title":"The low-toxicity versions of LPS, MPL\u00ae adjuvant and RC529, are efficient adjuvants for CD4+ T cells","volume":"78","author":"Thompson","year":"2005","journal-title":"J. Leukoc. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.imbio.2013.05.006","article-title":"Enhancement of humoral and cellular immune responses by monophosphoryl lipid A (MPLA) as an adjuvant to the rabies vaccine in BALB\/c mice","volume":"218","author":"Hu","year":"2013","journal-title":"Immunobiology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2018.12.029","article-title":"The vaccine adjuvant MPLA activates glycolytic metabolism in mouse mDC by a JNK-dependent activation of mTOR-signaling","volume":"106","author":"Goretzki","year":"2019","journal-title":"Mol. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Chen, C., Zhang, C., Li, R., Wang, Z., Yuan, Y., Li, H., Fu, Z., Zhou, M., and Zhao, L. (2019). Monophosphoryl-Lipid A (MPLA) is an Efficacious Adjuvant for Inactivated Rabies Vaccines. Viruses, 11.","DOI":"10.3390\/v11121118"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1016\/j.apsb.2022.05.028","article-title":"Fully synthetic Tn-based three-component cancer vaccine using covalently linked TLR4 ligand MPLA and iNKT cell agonist KRN-7000 as built-in adjuvant effectively protects mice from tumor development","volume":"12","author":"Yang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lage, D.P., Ribeiro, P.A., Dias, D.S., Mendon\u00e7a, D.V., Ramos, F.F., Carvalho, L.M., Steiner, B.T., Tavares, G.S., Martins, V.T., and Machado, A.S. (2020). Liposomal Formulation of ChimeraT, a Multiple T-Cell Epitope-Containing Recombinant Protein, Is a Candidate Vaccine for Human Visceral Leishmaniasis. Vaccines, 8.","DOI":"10.3390\/vaccines8020289"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune Responses Induced by the Leishmania (Leishmania) donovani A2 Antigen, but Not by the LACK Antigen, Are Protective against Experimental Leishmania (Leishmania) amazonensis Infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Lage, D.P., Vale, D.L., Linhares, F.P., Freitas, C.S., Machado, A.S., Cardoso, J.M.O., de Oliveira, D., Galvani, N.C., de Oliveira, M.P., and Oliveira-Da-Silva, J.A. (2022). A Recombinant Chimeric Protein-Based Vaccine Containing T-Cell Epitopes from Amastigote Proteins and Combined with Distinct Adjuvants, Induces Immunogenicity and Protection against Leishmania infantum Infection. Vaccines, 10.","DOI":"10.3390\/vaccines10071146"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"106412","DOI":"10.1016\/j.actatropica.2022.106412","article-title":"A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum","volume":"230","author":"Machado","year":"2022","journal-title":"Acta Trop."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/meth.2001.1261","article-title":"An Overview of Real-Time Quantitative PCR: Applications to Quantify Cytokine Gene Expression","volume":"25","author":"Giulietti","year":"2001","journal-title":"Methods"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"156143","DOI":"10.1016\/j.cyto.2023.156143","article-title":"Exploring drug repositioning for leishmaniasis treatment: Ivermectin plus polymeric micelles induce immunological response and protection against tegumentary leishmaniasis","volume":"164","author":"Freitas","year":"2023","journal-title":"Cytokine"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.vaccine.2016.04.067","article-title":"Strategic evaluation of vaccine candidate antigens for the prevention of Visceral Leishmaniasis","volume":"34","author":"Duthie","year":"2016","journal-title":"Vaccine"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2217\/imt.09.40","article-title":"Immunotherapy as a strategy for treatment of leishmaniasis: A review of the literature","volume":"1","author":"Okwor","year":"2009","journal-title":"Immunotherapy"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fcimb.2019.00427","article-title":"An Overview of Immunotherapeutic Approaches Against Canine Visceral Leishmaniasis: What Has Been Tested on Dogs and a New Perspective on Improving Treatment Efficacy","volume":"9","author":"Leite","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"104592","DOI":"10.1016\/j.cellimm.2022.104592","article-title":"A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis","volume":"380","author":"Ostolin","year":"2022","journal-title":"Cell. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/jac\/dkr485","article-title":"Treatment of Leishmania donovani-infected hamsters with miltefosine: Analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses","volume":"67","author":"Gupta","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.1128\/IAI.00394-07","article-title":"Leish-111f, a Recombinant Polyprotein Vaccine That Protects against Visceral Leishmaniasis by Elicitation of CD4+ T Cells","volume":"75","author":"Coler","year":"2007","journal-title":"Infect. Immun."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Baharia, R.K., Tandon, R., Sharma, T., Suthar, M.K., Das, S., Siddiqi, M.I., Saxena, J.K., Sunder, S., and Dube, A. (2015). Recombinant NAD-dependent SIR-2 Protein of Leishmania donovani: Immunobiochemical Characterization as a Potential Vaccine against Visceral Leishmaniasis. PLoS Negl. Trop. Dis., 9.","DOI":"10.1371\/journal.pntd.0003557"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molimm.2020.06.010","article-title":"Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis","volume":"124","author":"Lage","year":"2020","journal-title":"Mol. Immunol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.parint.2014.04.002","article-title":"A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study","volume":"63","author":"Joshi","year":"2014","journal-title":"Parasitol. Int."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"304","DOI":"10.7555\/JBR.30.20150125","article-title":"Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB\/c mice","volume":"30","author":"Sukhbir","year":"2016","journal-title":"J. Biomed. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"104529","DOI":"10.1016\/j.cellimm.2022.104529","article-title":"Dipeptidylcarboxypeptidase of Leishmania donovani: A potential vaccine molecule against experimental visceral leishmaniasis","volume":"375","author":"Balodi","year":"2022","journal-title":"Cell. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00436-011-2628-5","article-title":"Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB\/c mice using different doses and routes of inoculation of parasites","volume":"110","author":"Oliveira","year":"2012","journal-title":"Parasitol. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3024.2006.00817.x","article-title":"Immunohistological features of visceral leishmaniasis in BALB\/c mice","volume":"28","author":"Carrion","year":"2006","journal-title":"Parasite Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.parint.2016.07.005","article-title":"Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system","volume":"65","author":"Duarte","year":"2016","journal-title":"Parasitol. Int."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"155319","DOI":"10.1016\/j.cyto.2020.155319","article-title":"Lupeol and amphotericin B mediate synergistic anti-leishmanial immunomodulatory effects in Leishmania donovani-infected BALB\/c mice","volume":"137","author":"Das","year":"2021","journal-title":"Cytokine"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"108274","DOI":"10.1016\/j.intimp.2021.108274","article-title":"In vitro and in vivo therapeutic potentials of 6-gingerol in combination with amphotericin B for treatment of Leishmania major infection: Powerful synergistic and multifunctional effects","volume":"101","author":"Keyhani","year":"2021","journal-title":"Int. Immunopharmacol."}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/12\/6\/851\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:54:11Z","timestamp":1760126051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/12\/6\/851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":54,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["biology12060851"],"URL":"https:\/\/doi.org\/10.3390\/biology12060851","relation":{},"ISSN":["2079-7737"],"issn-type":[{"value":"2079-7737","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]}}}